В. В. Семиглазов
First Pavlov State Medical University of St. Petersburg · 272 works · 1,155 citations · h-index 12
Top works
- Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer
- [Interim results of a prospective randomized study of self-examination for early detection of breast cancer (Russia/St.Petersburg/WHO)].
- [Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer].
- International rehabilitation model for oncological patients
- PHYSICAL METHODS OF REHABILITATION IN PATIENTS WITH LUNG CANCER: A SCIENTOMETRIC ANALYSIS OF EVIDENCE-BASED RESEARCH
- [Preliminary results of the Russia (St.Petersburg)/WHO program for the evaluation of the effectiveness of breast self-examination].
- Tamoxifen therapy for cyclical mastalgia: dose randomized trial
- EPIDEMIOLOGY AND SCREENING FOR BREAST CANCER
- Prognostic and predictive factors in breast cancer
- Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors
- Anastrazol (A) vs tamoxifen (T) vs combine (A+T) as neoadjuvant endocrine therapy of postmenopausal breast cancer patients
- SENTINEL LYMPH NODE BIOPSY IN EARLY BREAST CANCER: THE EXPERIENCE OF THE N.N. PETROV RESEARCH INSTITUTE OF ONCOLOGY
- Scientometric analysis of evidence-based studies of rehabilitation physical factors for breast cancer patients
- Model for making diagnostic decisions in multiparametric ultrasound of breast lesions
- Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer
- Twenty-year experience of examining biopsies of signal lymph nodes in breast cancer
- 9 Breast-conserving surgery after preoperative endocrine therapy versus chemotherapy in postmenopausal patients with estrogen-receptor-positive breast cancer
- CHEMOTHERAPY BREAST CANCER MODERN VIEW ON THE PROBLEM
- Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
- [Adjuvant chemotherapy for breast cancer: search for new ways of planning].